Zhejiang University's Run Run Shaw Hospital Develops "Bone Glue", Revolutionizing Orthopedic Treatment
Release time:
2025-09-19
On September 9th, Run Run Shaw Hospital, affiliated with Zhejiang University's School of Medicine, announced a significant scientific achievement: the self - developed "Bone 02" bone glue for fractured bones. This innovative biomaterial can bond and fix bone fragments in the human blood environment, potentially changing traditional orthopedic treatments and reducing the use of metal implants.
Fractures are common clinical injuries, typically treated with metal implants like screws and plates. However, these methods struggle with comminuted fractures. Lin Xianfeng, a deputy chief physician at the hospital's orthopedics department, pointed out that traditional metal fixation has issues such as inaccurate anatomical reduction, time - consuming small bone - fragment fixation, and potential bone - fragment loss, which can lead to poor healing and arthritis, especially in joints.
To solve these problems, Lin's team was inspired by oysters' adhesion mechanism. They developed "Bone 02" by specially proportioning natural inorganic and organic components of the human body. This bone glue can bond strongly within 2 - 3 minutes in a blood - wet environment, is easy to use, boosting surgical efficiency. It's fully biodegradable, being absorbed about six months after bone healing, thus avoiding the pain of a second operation.
Currently, Run Run Shaw Hospital, along with other medical institutions, completed a multi - center randomized controlled clinical study on comminuted - fracture bonding treatment. "Bone 02" demonstrated good safety and efficacy in over 150 patients, meeting all preset standards.
A young worker with a comminuted wrist fracture was a case in point. The traditional treatment would involve large incisions, high risks, and a second operation. With "Bone 02", doctors used a 2 - 3 cm minimally invasive incision, completing the bonding in 3 minutes. Three - month follow - up showed excellent healing and full wrist - joint function recovery.
Lin Xianfeng said they hope patients can have fractures bonded with a simple injection in the future, shortening recovery time. The bone glue is applicable to various fractures throughout the body, especially hard - to - fix small fragments. Its quick - bonding and easy - use features also hold promise for defense, military, and disaster - rescue scenarios.
This innovation represents a major breakthrough in China's minimally invasive fracture treatment and brings new hope to global orthopedics.
Previous article
Latest developments
Recently, Frigid Zone Medicine, an authoritative international journal in the field of cryomedicine, published an important review titled "Advances in the Detection Methods for Assessing the Viability of Cryopreserved Samples". Written by the team of Yinfeng Cryomedical Research Center, the article systematically reviews and analyzes various detection techniques currently used to evaluate the viability of cryopreserved cells, tissues, and organs. It also proposes key directions from the perspectives of methodological integration and future instrument development, offering crucial theoretical support and practical guidance for the long - term cryopreservation of complex tissues and organs.
Recently, the "Novel Technology for Ultra-Low Temperature Cryopreservation, Activation, and Transplantation of Human Ovarian Tissue," developed through a collaborative effort between Shandong Yinfeng Life Science Research Institute and Beijing University of Chinese Medicine Shenzhen Hospital, has been awarded the 2025 Shandong Refrigeration and Air Conditioning Science and Technology Award. This groundbreaking technology pioneers a new pathway for female fertility preservation, marking a significant leap in China’s interdisciplinary advancements in reproductive medicine and cryobiology.
On May 19, a delegation from the Chinese Training Workshop for Government Officials of Developing Countries visited the exhibition hall of Yinfeng Biological Group's Cryomedicine Research Center. Government officials from multiple countries gained in-depth insights into Yinfeng’s innovative achievements in cryobiomedicine, cell storage, genetic technology, and other fields. They engaged in discussions with the delegation on technology transfer and international cooperation, contributing to the building of a global community with a shared future for humanity.
On the morning of May 17, 2025, an immersive exploration into life sciences and cryomedicine concluded successfully at Jinan Yinfeng Biological Science Park. Hosted by the Shandong Yinfeng Life Science Research Institute, this event offered members a firsthand look into the research base through activities such as ultra-low temperature cryotherapy experiences, brainwave signal acquisition system trials, and expert panel discussions. Participants witnessed the infinite possibilities that cryogenic technology and life sciences hold for humanity.
The international academic platform ScholarGPS recently announced its global lists of Highly Ranked Scholars - Lifetime and Highly Ranked Scholars - Prior 5 Years, recognizing the top 0.05% of scholars across various disciplines. Among the selected Chinese scholars are national-level talents, leading figures in specialized fields, and seasoned academics dedicated to long-term research.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155507
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
